|
|
| Shares
|
| Value
|
Common Stocks (continued)
|
Biotechnology (cont’d.)
|
Blueprint Medicines Corp.*
| 74,726
|
| $7,088,508
|
Bridgebio Pharma, Inc.*
| 120,772
|
| 3,734,270
|
Cabaletta Bio, Inc.*(a)
| 42,890
|
| 731,703
|
Celldex Therapeutics, Inc.*
| 15,559
|
| 653,011
|
CG oncology, Inc.*
| 18,312
|
| 803,897
|
Crinetics Pharmaceuticals, Inc.*(a)
| 162,534
|
| 7,608,217
|
Cytokinetics, Inc.*
| 9,197
|
| 644,802
|
Deciphera Pharmaceuticals, Inc.*
| 169,948
|
| 2,673,282
|
Disc Medicine, Inc.*
| 23,160
|
| 1,441,942
|
Ideaya Biosciences, Inc.*
| 59,551
|
| 2,613,098
|
Immunocore Holdings PLC (United Kingdom), ADR*(a)
| 40,389
|
| 2,625,285
|
Immunome, Inc.*(a)
| 43,250
|
| 1,067,410
|
Immunovant, Inc.*(a)
| 88,997
|
| 2,875,493
|
Insmed, Inc.*(a)
| 104,906
|
| 2,846,100
|
Iovance Biotherapeutics, Inc.*(a)
| 44,903
|
| 665,462
|
Ironwood Pharmaceuticals, Inc.*(a)
| 80,157
|
| 698,168
|
KalVista Pharmaceuticals, Inc.*(a)
| 65,211
|
| 773,403
|
Krystal Biotech, Inc.*(a)
| 19,114
|
| 3,400,954
|
Kymera Therapeutics, Inc.*
| 51,806
|
| 2,082,601
|
Kyverna Therapeutics, Inc.*(a)
| 20,600
|
| 511,704
|
Legend Biotech Corp., ADR*
| 18,705
|
| 1,049,163
|
Lyell Immunopharma, Inc.*(a)
| 77,383
|
| 172,564
|
Madrigal Pharmaceuticals, Inc.*(a)
| 13,473
|
| 3,597,830
|
Merus NV (Netherlands)*(a)
| 47,652
|
| 2,145,770
|
MoonLake Immunotherapeutics*(a)
| 16,260
|
| 816,740
|
Natera, Inc.*
| 69,803
|
| 6,384,182
|
Neurocrine Biosciences, Inc.*
| 9,950
|
| 1,372,304
|
Nuvalent, Inc. (Class A Stock)*(a)
| 56,887
|
| 4,271,645
|
Olema Pharmaceuticals, Inc.*(a)
| 69,310
|
| 784,589
|
Opthea Ltd. (Australia), ADR*
| 98,656
|
| 405,476
|
Prelude Therapeutics, Inc.*(a)
| 37,478
|
| 177,646
|
Protagonist Therapeutics, Inc.*
| 50,410
|
| 1,458,361
|
Prothena Corp. PLC (Ireland)*
| 13,834
|
| 342,668
|
RAPT Therapeutics, Inc.*
| 51,551
|
| 462,928
|
Replimune Group, Inc.*(a)
| 53,971
|
| 440,943
|
REVOLUTION Medicines, Inc.*
| 66,670
|
| 2,148,774
|
Rhythm Pharmaceuticals, Inc.*
| 28,187
|
| 1,221,343
|
Soleno Therapeutics, Inc.*(a)
| 28,393
|
| 1,215,220
|
SpringWorks Therapeutics, Inc.*(a)
| 72,797
|
| 3,583,068
|
Travere Therapeutics, Inc.*(a)
| 168,435
|
| 1,298,634
|
Ultragenyx Pharmaceutical, Inc.*
| 92,109
|
| 4,300,569
|
Vaxcyte, Inc.*(a)
| 94,121
|
| 6,429,406
|
Vericel Corp.*
| 19,960
|
| 1,038,319
|
Viking Therapeutics, Inc.*(a)
| 117,576
|
| 9,641,232
|
Xencor, Inc.*
| 35,252
|
| 780,127
|
Xenon Pharmaceuticals, Inc. (Canada)*
| 95,265
|
| 4,101,158
|
|
|
|
|
|
| 130,193,600
|
Broadline Retail — 1.0%
|
Global-e Online Ltd. (Israel)*(a)
| 68,800
|
| 2,500,880
|
Ollie’s Bargain Outlet Holdings, Inc.*(a)
| 90,701
|
| 7,217,079
|
Savers Value Village, Inc.*(a)
| 116,593
|
| 2,247,913
|
|
|
|
|
|
| 11,965,872
|
Building Products — 2.4%
|
AAON, Inc.(a)
| 24,962
|
| 2,199,152
|